_id

690dae97ccc777a4e85d0a9c

Ticker

AMRX

Name

Amneal Pharmaceuticals, Inc. Class A Common Stock

Exchange

NYSE

Address

400 Crossing Boulevard, Bridgewater, NJ, United States, 08807

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.amneal.com

Description

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.

Last Close

12.21

Volume

1000080

Current Price

12.46

Change

2.0475020475020473

Last Updated

2025-11-28T12:12:50.878Z

Image

data:image/webp;base64,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

Ipo Date

2009-01-15T00:00:00.000Z

Market Cap

3935823872

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8126433333333334

Sentiment Sources

30

Rating

4.25

Target Price

13.5

Strong Buy

1

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

784513000

Cost Of Revenue

510539000

Gross Profit

273974000

Operating Expenses

274091000

Operating Income

-117000

Interest Expense

62814000

Pretax Income

-5223000

Net Income

2369000

Eps

0.007294752335614034

Dividends Per Share

-

Shares Outstanding

314362920

Income Tax Expense

-23355000

EBITDA

111664000

Operating Margin

-0.014913710798928764

Total Other Income Expense Net

-5106000

Cash

201249000

Short Term Investments

-

Receivables

924137000

Inventories

614500000

Total Current Assets

1838478000

Property Plant Equipment

538055000

Total Assets

3599874000

Payables

266358000

Short Term Debt

21471000

Long Term Debt

2566500000

Total Liabilities

3709829000

Equity

-109458000

Depreciation

54073000

Change In Working Capital

-50738000

Cash From Operations

118450000

Capital Expenditures

15050000

Cash From Investing

-22464000

Cash From Financing

59443000

Net Change In Cash

154790000

PE

1252.0001

PB

-36.967922308099915

ROE

-2.164300462277769

ROA

0.06580785883061463

FCF

103400000

Fcf Percent

0.13180151253070377

Piotroski FScore

3

Health Score

43

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

3

Economic Moat Investing Score

6.8

Garp Investing Score

3

Growth Investing Score

3.5

Momentum Investing Score

6

Net Net Investing Score

2

Quality Investing Score

2.5

Value Investing Score

1.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

784513000

Quarters > 0 > income Statement > cost Of Revenue

510539000

Quarters > 0 > income Statement > gross Profit

273974000

Quarters > 0 > income Statement > operating Expenses

274091000

Quarters > 0 > income Statement > operating Income

-117000

Quarters > 0 > income Statement > interest Expense

62814000

Quarters > 0 > income Statement > pretax Income

-5223000

Quarters > 0 > income Statement > net Income

2369000

Quarters > 0 > income Statement > eps

0.007294752335614034

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

324754000

Quarters > 0 > income Statement > income Tax Expense

-23355000

Quarters > 0 > income Statement > EBITDA

111664000

Quarters > 0 > income Statement > operating Margin

-0.014913710798928764

Quarters > 0 > income Statement > total Other Income Expense Net

-5106000

Quarters > 0 > balance Sheet > cash

201249000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

924137000

Quarters > 0 > balance Sheet > inventories

614500000

Quarters > 0 > balance Sheet > total Current Assets

1838478000

Quarters > 0 > balance Sheet > property Plant Equipment

538055000

Quarters > 0 > balance Sheet > total Assets

3599874000

Quarters > 0 > balance Sheet > payables

266358000

Quarters > 0 > balance Sheet > short Term Debt

21471000

Quarters > 0 > balance Sheet > long Term Debt

2566500000

Quarters > 0 > balance Sheet > total Liabilities

3709829000

Quarters > 0 > balance Sheet > equity

-109458000

Quarters > 0 > cash Flow > net Income

18132000

Quarters > 0 > cash Flow > depreciation

54073000

Quarters > 0 > cash Flow > change In Working Capital

-50738000

Quarters > 0 > cash Flow > cash From Operations

118450000

Quarters > 0 > cash Flow > capital Expenditures

15050000

Quarters > 0 > cash Flow > cash From Investing

-22464000

Quarters > 0 > cash Flow > cash From Financing

59443000

Quarters > 0 > cash Flow > net Change In Cash

154790000

Quarters > 0 > ratios > PE

0.007294752335614034

Quarters > 0 > ratios > PB

-36.967922308099915

Quarters > 0 > ratios > ROE

-2.164300462277769

Quarters > 0 > ratios > ROA

0.06580785883061463

Quarters > 0 > ratios > FCF

103400000

Quarters > 0 > ratios > Piotroski FScore

3

Quarters > 0 > ratios > fcf Percent

0.13180151253070377

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

724508000

Quarters > 1 > income Statement > cost Of Revenue

438255000

Quarters > 1 > income Statement > gross Profit

286253000

Quarters > 1 > income Statement > operating Expenses

174881000

Quarters > 1 > income Statement > operating Income

111372000

Quarters > 1 > income Statement > interest Expense

65101000

Quarters > 1 > income Statement > pretax Income

51711000

Quarters > 1 > income Statement > net Income

22417000

Quarters > 1 > income Statement > eps

0.06953961838052133

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

322363000

Quarters > 1 > income Statement > income Tax Expense

16101000

Quarters > 1 > income Statement > EBITDA

176925000

Quarters > 1 > income Statement > operating Margin

15.372086988687494

Quarters > 1 > income Statement > total Other Income Expense Net

-59661000

Quarters > 1 > balance Sheet > cash

81186000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

849265000

Quarters > 1 > balance Sheet > inventories

608973000

Quarters > 1 > balance Sheet > total Current Assets

1584692000

Quarters > 1 > balance Sheet > property Plant Equipment

546294000

Quarters > 1 > balance Sheet > total Assets

3422788000

Quarters > 1 > balance Sheet > payables

666817000

Quarters > 1 > balance Sheet > short Term Debt

335406000

Quarters > 1 > balance Sheet > long Term Debt

2146403000

Quarters > 1 > balance Sheet > total Liabilities

3469519000

Quarters > 1 > balance Sheet > equity

-112533000

Quarters > 1 > cash Flow > net Income

35610000

Quarters > 1 > cash Flow > depreciation

60113000

Quarters > 1 > cash Flow > change In Working Capital

-35108000

Quarters > 1 > cash Flow > cash From Operations

83819000

Quarters > 1 > cash Flow > capital Expenditures

26502000

Quarters > 1 > cash Flow > cash From Investing

-26547000

Quarters > 1 > cash Flow > cash From Financing

-41687000

Quarters > 1 > cash Flow > net Change In Cash

15416000

Quarters > 1 > ratios > PE

0.06953961838052133

Quarters > 1 > ratios > PB

-35.69302320208295

Quarters > 1 > ratios > ROE

-19.920378911074973

Quarters > 1 > ratios > ROA

0.6549339310526975

Quarters > 1 > ratios > FCF

57317000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.0791116178151242

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

695420000

Quarters > 2 > income Statement > cost Of Revenue

439529000

Quarters > 2 > income Statement > gross Profit

255891000

Quarters > 2 > income Statement > operating Expenses

155544000

Quarters > 2 > income Statement > operating Income

100347000

Quarters > 2 > income Statement > interest Expense

56939000

Quarters > 2 > income Statement > pretax Income

37486000

Quarters > 2 > income Statement > net Income

12195000

Quarters > 2 > income Statement > eps

0.037643420041301265

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

323961000

Quarters > 2 > income Statement > income Tax Expense

12868000

Quarters > 2 > income Statement > EBITDA

154584000

Quarters > 2 > income Statement > operating Margin

14.429697161427626

Quarters > 2 > income Statement > total Other Income Expense Net

-62861000

Quarters > 2 > balance Sheet > cash

59187000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

800294000

Quarters > 2 > balance Sheet > inventories

601433000

Quarters > 2 > balance Sheet > total Current Assets

1510450000

Quarters > 2 > balance Sheet > property Plant Equipment

522748000

Quarters > 2 > balance Sheet > total Assets

3365249000

Quarters > 2 > balance Sheet > payables

192532000

Quarters > 2 > balance Sheet > short Term Debt

337544000

Quarters > 2 > balance Sheet > long Term Debt

2153979000

Quarters > 2 > balance Sheet > total Liabilities

3424638000

Quarters > 2 > balance Sheet > equity

-131667000

Quarters > 2 > cash Flow > net Income

24618000

Quarters > 2 > cash Flow > depreciation

60159000

Quarters > 2 > cash Flow > change In Working Capital

-106380000

Quarters > 2 > cash Flow > cash From Operations

7408000

Quarters > 2 > cash Flow > capital Expenditures

18322000

Quarters > 2 > cash Flow > cash From Investing

-17798000

Quarters > 2 > cash Flow > cash From Financing

-39166000

Quarters > 2 > cash Flow > net Change In Cash

-50026000

Quarters > 2 > ratios > PE

0.037643420041301265

Quarters > 2 > ratios > PB

-30.657294994189893

Quarters > 2 > ratios > ROE

-9.262001868349701

Quarters > 2 > ratios > ROA

0.3623803171771242

Quarters > 2 > ratios > FCF

-10914000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-0.015694112910183775

Quarters > 2 > health Score

31

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

730518000

Quarters > 3 > income Statement > cost Of Revenue

467645000

Quarters > 3 > income Statement > gross Profit

262873000

Quarters > 3 > income Statement > operating Expenses

187080000

Quarters > 3 > income Statement > operating Income

75793000

Quarters > 3 > income Statement > interest Expense

61662000

Quarters > 3 > income Statement > pretax Income

-15319000

Quarters > 3 > income Statement > net Income

-31081000

Quarters > 3 > income Statement > eps

-0.10030982733580765

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

309850000

Quarters > 3 > income Statement > income Tax Expense

5423000

Quarters > 3 > income Statement > EBITDA

112473000

Quarters > 3 > income Statement > operating Margin

10.375240582709804

Quarters > 3 > income Statement > total Other Income Expense Net

-91112000

Quarters > 3 > balance Sheet > cash

110552000

Quarters > 3 > balance Sheet > short Term Investments

1868000

Quarters > 3 > balance Sheet > receivables

775731000

Quarters > 3 > balance Sheet > inventories

612454000

Quarters > 3 > balance Sheet > total Current Assets

1587806000

Quarters > 3 > balance Sheet > property Plant Equipment

523693000

Quarters > 3 > balance Sheet > total Assets

3501445000

Quarters > 3 > balance Sheet > payables

259844000

Quarters > 3 > balance Sheet > short Term Debt

340255000

Quarters > 3 > balance Sheet > long Term Debt

2161790000

Quarters > 3 > balance Sheet > total Liabilities

3545983000

Quarters > 3 > balance Sheet > equity

-109267000

Quarters > 3 > cash Flow > net Income

-20742000

Quarters > 3 > cash Flow > depreciation

66130000

Quarters > 3 > cash Flow > change In Working Capital

21855000

Quarters > 3 > cash Flow > cash From Operations

118078000

Quarters > 3 > cash Flow > capital Expenditures

23064000

Quarters > 3 > cash Flow > cash From Investing

-16059000

Quarters > 3 > cash Flow > cash From Financing

-61204000

Quarters > 3 > cash Flow > net Change In Cash

40075000

Quarters > 3 > ratios > PE

-0.10030982733580765

Quarters > 3 > ratios > PB

-35.33300081451856

Quarters > 3 > ratios > ROE

28.445001693100387

Quarters > 3 > ratios > ROA

-0.8876620937927056

Quarters > 3 > ratios > FCF

95014000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

0.13006387248500378

Quarters > 3 > health Score

43

Valuation > metrics > PE

1252.0001

Valuation > metrics > PB

-36.967922308099915

Valuation > final Score

20

Valuation > verdict

4908.0% Overvalued

Profitability > metrics > ROE

-2.164300462277769

Profitability > metrics > ROA

0.1288565868071307

Profitability > metrics > Net Margin

0.003019707767748909

Profitability > final Score

1

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-0.0018626420861591365

Risk > final Score

30

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.387396683447464

Liquidity > metrics > Quick Ratio

4.2524485024094165

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

50

Prev Profitabilities > 0

9

Prev Profitabilities > 1

5

Prev Profitabilities > 2

40

Prev Risks > 0

37

Prev Risks > 1

37

Prev Risks > 2

35

Prev Liquidities > 0

88

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:24:29.778Z